Protective Effect of Shenxiong Injection on Cerebral Ischemic/Reperfusion Injury in Rats

Xiao-Dong Chen,Yong-Jun Cao,Yin-Ming Wang,Zheng Tao,Chun-Feng Liu
DOI: https://doi.org/10.3760/cma.j.issn.1673-4165.2006.04.005
2006-01-01
Abstract:Objectives: To observe the effect of Shenxiong injection (salivae miltiorrhizae, liguspyragine hydrochloride and glucose injection) on behavioral changes, infarct volume and histopathology changes after cerebral ischemia/reperfusion in rats, and to explore its neuroprotective effect and mechanism. Methods: Thirty three male SD rats were randomly assigned to four groups: sham-operated group, control group, ligustrazine-treated group and Shenxiong-treated group. Cerebral ischemia (1 hour)/reperfusion model was established by occluding middle cerebral artery with intraluminal suture method. The behavioral changes and cerebral infarct volume were evaluated by the Longa's score (5 points) and triphenyltetrazolium chloride (TTC) staining, and the ultrastructure changes in the ischemic margin were observed under the electron microscope at 24 hours after reperfusion. Results: There were no significant differences among the 4 groups on Longa's score both at 6 and 24 hours after the reperfusion. However, the Longa's score in the Shenxiong-treated group was improved more significantly at 24 hours after the reperfusion than that at 6 hours after the reperfusion (P<0.05). Compared with the control group, the cerebral infarct volume in the Shenxiong-treated group and ligustrazine-treated group decreased significantly (P<0.05), but there was no significant differences between Shenxiong-treated group and ligustrazine-treated group. The severity of neuron damage both in Shenxiong-treated group and ligustrazine-treated group was reduced more significant than that in the control group (P<0.05); the neuron changes of ultrastructure in the ischemic margin were lighter in the Shenxiong-treated group than those in the control group under the electron microscope, and it was better than the ligustrazine-treated group. Conclusions: Shenxiong injection may have certain neuroprotective effects on cerebral ischemia/reperfusion injury, which is better than ligustrazine alone.
What problem does this paper attempt to address?